Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,676 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Study protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) study.
Kojima T, Kaneko A, Hirano Y, Ishikawa H, Miyake H, Oguchi T, Takagi H, Yabe Y, Kato T, Ito T, Terabe K, Fukaya N, Kanayama Y, Shioura T, Funahashi K, Hayashi M, Kato D, Matsubara H, Fujibayashi T, Kojima M, Ishiguro N; TBC. Kojima T, et al. Among authors: ito t. Mod Rheumatol. 2012 Jun;22(3):339-45. doi: 10.1007/s10165-011-0518-4. Epub 2011 Sep 3. Mod Rheumatol. 2012. PMID: 21892671
Inhibitory effect of bFGF on endochondral heterotopic ossification.
Sakano S, Hasegawa Y, Murata Y, Ito T, Genda E, Iwata H, Ishiguro N, Seo H. Sakano S, et al. Among authors: ito t. Biochem Biophys Res Commun. 2002 May 3;293(2):680-5. doi: 10.1016/S0006-291X(02)00273-5. Biochem Biophys Res Commun. 2002. PMID: 12054522
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.
Hirabara S, Takahashi N, Fukaya N, Miyake H, Yabe Y, Kaneko A, Ito T, Oguchi T, Kida D, Hirano Y, Fujibayashi T, Sugiura F, Hayashi M, Funahashi K, Hanabayashi M, Asai S, Ishiguro N, Kojima T. Hirabara S, et al. Among authors: ito t. Clin Rheumatol. 2014 Sep;33(9):1247-54. doi: 10.1007/s10067-014-2711-2. Epub 2014 Jun 28. Clin Rheumatol. 2014. PMID: 24970596 Free PMC article.
Longterm retention rate and risk factor for discontinuation due to insufficient efficacy and adverse events in Japanese patients with rheumatoid arthritis receiving etanercept therapy.
Matsubara H, Kojima T, Kaneko A, Hirano Y, Ishikawa H, Hattori Y, Miyake H, Oguchi T, Takagi H, Yabe Y, Kato T, Ito T, Fukaya N, Kanayama Y, Shioura T, Hayashi M, Fujibayashi T, Takahashi N, Funahashi K, Kato D, Hanabayashi M, Terabe K, Ishiguro N. Matsubara H, et al. Among authors: ito t. J Rheumatol. 2014 Aug;41(8):1583-9. doi: 10.3899/jrheum.130901. Epub 2014 Jul 15. J Rheumatol. 2014. PMID: 25028370
Disease activity early in treatment as a predictor of future low disease activity in RA patients treated with iguratimod.
Yoshioka Y, Takahashi N, Kaneko A, Hirano Y, Kanayama Y, Kanda H, Takagi H, Ito T, Kato T, Saito K, Funahashi K, Asai S, Takemoto T, Terabe K, Asai N, Ishiguro N, Kojima T. Yoshioka Y, et al. Among authors: ito t. Mod Rheumatol. 2016;26(2):169-74. doi: 10.3109/14397595.2015.1069475. Epub 2015 Aug 19. Mod Rheumatol. 2016. PMID: 26140467
Improved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
Kojima T, Takahashi N, Funahashi K, Asai S, Terabe K, Kaneko A, Hirano Y, Hayashi M, Miyake H, Oguchi T, Takagi H, Kanayama Y, Yabe Y, Watanabe T, Fujibayashi T, Shioura T, Ito T, Yoshioka Y, Ishikawa H, Asai N, Takemoto T, Kojima M, Ishiguro N. Kojima T, et al. Among authors: ito t. Clin Rheumatol. 2016 Apr;35(4):863-71. doi: 10.1007/s10067-016-3201-5. Epub 2016 Feb 5. Clin Rheumatol. 2016. PMID: 26846135
Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study.
Hattori Y, Kojima T, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Terabe K, Yabe Y, Miyake H, Kato T, Takagi H, Hayashi M, Ito T, Kanayama Y, Oguchi T, Takahashi N, Ishikawa H, Funahashi K, Ishiguro N. Hattori Y, et al. Among authors: ito t. J Rheumatol. 2016 Aug;43(8):1475-9. doi: 10.3899/jrheum.151006. Epub 2016 Jun 15. J Rheumatol. 2016. PMID: 27307531
High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumab.
Hattori Y, Kojima T, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Yabe Y, Oguchi T, Kanayama Y, Miyake H, Kato T, Takagi H, Hayashi M, Ito T, Shioura T, Takahashi N, Ishikawa H, Funahashi K, Ishiguro N. Hattori Y, et al. Among authors: ito t. Mod Rheumatol. 2018 Jan;28(1):119-125. doi: 10.1080/14397595.2017.1317320. Epub 2017 May 2. Mod Rheumatol. 2018. PMID: 28463029
Predictors of biologic discontinuation due to insufficient response in patients with rheumatoid arthritis who achieved clinical remission with biologic treatment: A multicenter observational cohort study.
Asai S, Fujibayashi T, Oguchi T, Hanabayashi M, Hayashi M, Matsubara H, Ito T, Yabe Y, Watanabe T, Hirano Y, Kanayama Y, Kaneko A, Kato T, Takagi H, Takahashi N, Funahashi K, Takemoto T, Asai N, Watanabe T, Ishiguro N, Kojima T. Asai S, et al. Among authors: ito t. Mod Rheumatol. 2018 Mar;28(2):221-226. doi: 10.1080/14397595.2017.1332558. Epub 2017 Jul 13. Mod Rheumatol. 2018. PMID: 28701065
Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicenter registry study.
Suzuki M, Kojima T, Takahashi N, Asai S, Terabe K, Kaneko A, Hirano Y, Hanabayashi M, Oguchi T, Takagi H, Kanayama Y, Yabe Y, Funahashi K, Fujibayashi T, Tsuboi S, Ito T, Yoshioka Y, Ishikawa H, Sobue Y, Nishiume T, Yokota Y, Ishiguro N. Suzuki M, et al. Among authors: ito t. Mod Rheumatol. 2021 Jul;31(4):796-802. doi: 10.1080/14397595.2021.1879428. Epub 2021 Feb 25. Mod Rheumatol. 2021. PMID: 33492191
11,676 results
You have reached the last available page of results. Please see the User Guide for more information.